Firefly Neuroscience (AIFF) Cash from Financing Activities (2010 - 2026)

Firefly Neuroscience's Cash from Financing Activities history runs 10 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 76.73% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $3.8 million, a 77.35% decrease from a year earlier, with the FY2025 full-year figure at $11.6 million, up 84.46% from the prior year.
• Cash from Financing Activities grew to $2.4 million in Q1 2026 per AIFF's latest filing, from $250000.0 in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $10.3 million in Q1 2025 and bottomed at -$87245.0 in Q2 2023.
• The 5-year median for Cash from Financing Activities is $945000.0 (2024), against an average of $1.7 million.
• Biggest YoY gain for Cash from Financing Activities was 3303.21% in 2023; the steepest drop was 1139.62% in 2023.
• Year by year, Cash from Financing Activities stood at $425000.0 in 2022, then jumped by 404.94% to $2.1 million in 2023, then jumped by 106.2% to $4.4 million in 2024, then sank by 94.35% to $250000.0 in 2025, then surged by 854.4% to $2.4 million in 2026.
• Per Business Quant, the three latest AIFF Cash from Financing Activities figures stand at $2.4 million (Q1 2026), $250000.0 (Q4 2025), and -$19000.0 (Q3 2025).